New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Innovative software improves chronic rheumatic disease care

Innovative software improves chronic rheumatic disease care

(HealthDay)—For patients with chronic rheumatic disease, innovative software that aggregates, stores, and displays information can improve quality of care, according to research published online Nov.
Immunology & Rheumatology April 08,2024
Innovative software improves chronic rheumatic disease care

Innovative software improves chronic rheumatic disease care

(HealthDay)—For patients with chronic rheumatic disease, innovative software that aggregates, stores, and displays information can improve quality of care, according to research published online Nov.
Immunology & Rheumatology April 08,2024
Combined inhibition of TNF-alpha, IL-17 effective in RA model

Combined inhibition of TNF-alpha, IL-17 effective in RA model

(HealthDay)—Combined inhibition of tumor necrosis factor (TNF) α and interleukin (IL)-17 is more effective than single blockade in cultures of human fibroblast-like synoviocytes (FLS), according to an
Immunology & Rheumatology April 08,2024
Combined inhibition of TNF-alpha, IL-17 effective in RA model

Combined inhibition of TNF-alpha, IL-17 effective in RA model

(HealthDay)—Combined inhibition of tumor necrosis factor (TNF) α and interleukin (IL)-17 is more effective than single blockade in cultures of human fibroblast-like synoviocytes (FLS), according to an
Immunology & Rheumatology April 08,2024
Brain activity linked to TNF inhibitor response in RA

Brain activity linked to TNF inhibitor response in RA

Patients with rheumatoid arthritis who respond to tumor necrosis factor inhibitors show changes in activity in pain-related areas of the brain before clinical signs of improvement are observed, accord
Immunology & Rheumatology April 08,2024
Brain activity linked to TNF inhibitor response in RA

Brain activity linked to TNF inhibitor response in RA

Patients with rheumatoid arthritis who respond to tumor necrosis factor inhibitors show changes in activity in pain-related areas of the brain before clinical signs of improvement are observed, accord
Immunology & Rheumatology April 08,2024
Gender, high DAS28-P index predictive of pain in early RA

Gender, high DAS28-P index predictive of pain in early RA

(HealthDay) -- For patients with rheumatoid arthritis (RA), female gender and having a high proportion of disease activity score (DAS28) attributable to patient-reported components (joint tenderness a
Immunology & Rheumatology April 08,2024
Gender, high DAS28-P index predictive of pain in early RA

Gender, high DAS28-P index predictive of pain in early RA

(HealthDay) -- For patients with rheumatoid arthritis (RA), female gender and having a high proportion of disease activity score (DAS28) attributable to patient-reported components (joint tenderness a
Immunology & Rheumatology April 08,2024
Patient-Rated elbow evaluation most responsive instrument

Patient-Rated elbow evaluation most responsive instrument

The Patient-Rated Elbow Evaluation form is the most responsive instrument to identify and quantify elbow joint-specific changes before and after total elbow arthroplasty, according to a study publishe
Immunology & Rheumatology April 08,2024
Patient-Rated elbow evaluation most responsive instrument

Patient-Rated elbow evaluation most responsive instrument

The Patient-Rated Elbow Evaluation form is the most responsive instrument to identify and quantify elbow joint-specific changes before and after total elbow arthroplasty, according to a study publishe
Immunology & Rheumatology April 08,2024
TNF inhibitors may not modify polyarticular JIA disease process

TNF inhibitors may not modify polyarticular JIA disease process

(HealthDay)—For children with polyarticular juvenile idiopathic arthritis (JIA), discontinuing medications is challenging, with high relapse rates, especially after discontinuation of tumor necrosis f
Immunology & Rheumatology April 08,2024
TNF inhibitors may not modify polyarticular JIA disease process

TNF inhibitors may not modify polyarticular JIA disease process

(HealthDay)—For children with polyarticular juvenile idiopathic arthritis (JIA), discontinuing medications is challenging, with high relapse rates, especially after discontinuation of tumor necrosis f
Immunology & Rheumatology April 08,2024
Increased insulin resistance in rheumatoid arthritis

Increased insulin resistance in rheumatoid arthritis

(HealthDay)—Patients with rheumatoid arthritis (RA) have elevated insulin resistance (IR), but this is not associated with increased atherosclerosis risk, according to a study published online Dec. 10
Immunology & Rheumatology April 08,2024
Increased insulin resistance in rheumatoid arthritis

Increased insulin resistance in rheumatoid arthritis

(HealthDay)—Patients with rheumatoid arthritis (RA) have elevated insulin resistance (IR), but this is not associated with increased atherosclerosis risk, according to a study published online Dec. 10
Immunology & Rheumatology April 08,2024
Risk factors ID'd for revision of total hip replacement

Risk factors ID'd for revision of total hip replacement

Younger, taller, and heavier patients who undergo primary total hip replacement are at a greater risk of needing a revision surgery, according to research published in the December issue ofArthr
Orthopedics & Sports medicine April 08,2024
Risk factors ID'd for revision of total hip replacement

Risk factors ID'd for revision of total hip replacement

Younger, taller, and heavier patients who undergo primary total hip replacement are at a greater risk of needing a revision surgery, according to research published in the December issue ofArthr
Orthopedics & Sports medicine April 08,2024
Death rate after hip, knee replacements has dropped sharply, study finds

Death rate after hip, knee replacements has dropped sharply, study finds

by Amy Norton, Healthday ReporterExperts credit advances in post-surgical care for lower risk.(HealthDay)—The risk of death from hip- or knee-replacement surgery has dropped substantially in recent ye
Orthopedics & Sports medicine April 08,2024
Death rate after hip, knee replacements has dropped sharply, study finds

Death rate after hip, knee replacements has dropped sharply, study finds

by Amy Norton, Healthday ReporterExperts credit advances in post-surgical care for lower risk.(HealthDay)—The risk of death from hip- or knee-replacement surgery has dropped substantially in recent ye
Orthopedics & Sports medicine April 08,2024
Knee injections for arthritis? Save your money, study says

Knee injections for arthritis? Save your money, study says

By Kathleen Doheny, HealthDay ReporterHyaluronic acid has little effect on pain, none on function, new review states.(HealthDay) -- It's not good news for baby boomers with arthritic knees: Inject
Orthopedics & Sports medicine April 08,2024
Knee injections for arthritis? Save your money, study says

Knee injections for arthritis? Save your money, study says

By Kathleen Doheny, HealthDay ReporterHyaluronic acid has little effect on pain, none on function, new review states.(HealthDay) -- It's not good news for baby boomers with arthritic knees: Inject
Orthopedics & Sports medicine April 08,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com